Global Ophthalmic Viscoelastic Devices Market Size, Share, and Trends Analysis Report, By Type (Cohesive Ophthalmic Viscoelastic Devices and Dispersive Ophthalmic Viscoelastic Devices), By Application (Cataract Surgery, Glaucoma Surgery, Corneal Transplantation, and Vitreoretinal Surgery), Forecast (2022-2028)

The global ophthalmic viscoelastic devices market is anticipated to grow at a significant CAGR of 3.9% during the forecast period (2022-2028). Ophthalmic viscoelastic devices are used by ophthalmologists in different eye surgeries, such as cataract surgery and glaucoma surgery for protecting the delicate ocular structures along with creating pressure in the anterior chamber, compartmentalizing inside the eye, and offering a faster and safer surgery with better recovery for the patients. The global ophthalmic viscoelastic devices market is growing due to the supportive government initiatives and awareness programs for vision impairment. The rising prevalence of cataract and glaucoma patients and eye surgeries performed across the globe is also boosting the growth of the market. According to a survey conducted by the Glaucoma Research Foundation in 2018, more than 120,000 are blind in the US due to glaucoma, accounting for 9% to 12% of the total blind cases. It is also estimated that around 3million Americans have glaucoma but only half of those get diagnosed. Additionally, the surge in the adoption of viscoelastic devices across the globe also boosts the growth of the global ophthalmic viscoelastic devices market in the forecast period.

The market players are also contributing significantly to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships, collaborations, and new launches, to stay competitive in the market. For instance, in May 2020, BVI acquired the ophthalmic viscoelastic device asset from Croma Pharma GmbH. They have also embarked on a research and development collaboration on additional products which will come in the foreseeable future. Similarly, in April 2021, the US Food and Drug Administration approved Bausch & Lomb Pvt Ltd. ClearVisc Dispersive Ophthalmic Viscosurgical Device for use in ophthalmic surgery to enrich the pipeline of ophthalmic surgical devices.

Market Coverage

• The market number available for – 2022-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape- Johnson & Johnson, Inc., Alcon Vision LLC, Bausch & Lomb Pvt Ltd., ZEISS International, Altacor, and RUMEX International Co., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Ophthalmic Viscoelastic Devices Market Report by Segment

By Type

• Cohesive Ophthalmic Viscoelastic Devices
• Dispersive Ophthalmic Viscoelastic Devices

By Application

• Cataract Surgery
• Glaucoma Surgery
• Corneal Transplantation
• Vitreoretinal Surgery

Global Ophthalmic Viscoelastic Devices Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa